These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 23756092

  • 1. Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgery.
    Tang XP, Li J, Yu LC, Chen YC, Shi SB, Zhu LR, Chen P.
    Lung Cancer; 2013 Aug; 81(2):273-9. PubMed ID: 23756092
    [Abstract] [Full Text] [Related]

  • 2. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
    Li J, Shi SB, Shi WL, Wang Y, Yu LC, Zhu LR, Ge LP.
    Transl Res; 2014 Jan; 163(1):27-35. PubMed ID: 24120632
    [Abstract] [Full Text] [Related]

  • 3. Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer.
    Li J, Hu YM, Du YJ, Zhu LR, Qian H, Wu Y, Shi WL.
    BMC Cancer; 2014 Nov 19; 14():848. PubMed ID: 25410981
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
    Warnecke-Eberz U, Baldus SE, Bollschweiler E, Hoelscher AH, Metzger R.
    Anticancer Res; 2008 Nov 19; 28(3A):1525-9. PubMed ID: 18630507
    [Abstract] [Full Text] [Related]

  • 7. Survivin expression impacts prognostically on NSCLC but not SCLC.
    Rosato A, Menin C, Boldrin D, Dalla Santa S, Bonaldi L, Scaini MC, Del Bianco P, Zardo D, Fassan M, Cappellesso R, Fassina A.
    Lung Cancer; 2013 Feb 19; 79(2):180-6. PubMed ID: 23218791
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P, Li J, Ge LP, Dai CH, Li XQ.
    Respirology; 2010 Apr 19; 15(3):501-9. PubMed ID: 20210890
    [Abstract] [Full Text] [Related]

  • 9. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
    Yeh KT, Wu YH, Lee MC, Wang L, Li CT, Chen CY, Lee H.
    Ann Surg Oncol; 2012 Mar 19; 19(3):734-42. PubMed ID: 21861227
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B, Pappot H, Holmstav J, Skov BG.
    Lung Cancer; 2009 Dec 19; 66(3):314-8. PubMed ID: 19324448
    [Abstract] [Full Text] [Related]

  • 11. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC.
    Luo YQ, Ming Z, Zhao L, Yao LJ, Dong H, Du JP, Wu SZ, Hu W.
    IUBMB Life; 2012 May 19; 64(5):423-31. PubMed ID: 22473740
    [Abstract] [Full Text] [Related]

  • 12. Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery.
    Dai CH, Li J, Shi SB, Yu LC, Ge LP, Chen P.
    Jpn J Clin Oncol; 2010 Apr 19; 40(4):327-35. PubMed ID: 20056675
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.
    Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370
    [Abstract] [Full Text] [Related]

  • 15. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E, Visca P, Novelli F, Casini B, Diodoro MG, Perrone-Donnorso R, Botti C, Sperduti I, Facciolo F, Milella M, Cecere FL, Cognetti F, Mottolese M.
    Eur J Surg Oncol; 2008 May 15; 34(5):593-8. PubMed ID: 17693049
    [Abstract] [Full Text] [Related]

  • 16. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG.
    Int J Mol Med; 2006 May 15; 17(5):937-44. PubMed ID: 16596284
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
    Cho HJ, Kim HR, Park YS, Kim YH, Kim DK, Park SI.
    Surg Oncol; 2015 Dec 15; 24(4):329-34. PubMed ID: 26690822
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V, Gregorc V, Pistola L, Mihaylova Z, Floriani I, Darwish S, Stracci F, Tofanetti FR, Ferraldeschi M, Di Carlo L, Ragusa M, Daddi G, Tonato M.
    Lung Cancer; 2004 Oct 15; 46(1):77-85. PubMed ID: 15364135
    [Abstract] [Full Text] [Related]

  • 19. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H.
    Cancer; 2007 Jul 01; 110(1):215-23. PubMed ID: 17508409
    [Abstract] [Full Text] [Related]

  • 20. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H, Kondo K, Fujino H, Kenzaki K, Miyoshi T, Sakiyama S, Tangoku A.
    Br J Cancer; 2006 Jul 03; 95(1):75-9. PubMed ID: 16755294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.